IUGNF (Imugene) Other Current Payables: $0.00 Mil (As of Dec. 2025)


IUGNF Imugene Ltd IUGNF
30 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is Imugene Other Current Payables?

Imugene IUGNF -8.05% 30 Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus rates IUGNF with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Imugene's Other Current Payables for the quarter that ended in Dec. 2025 was $0.00 Mil.

Imugene's quarterly Other Current Payables increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($3.18 Mil) but then declined from Jun. 2025 ($3.18 Mil) to Dec. 2025 ($0.00 Mil).

Imugene's annual Other Current Payables increased from Jun. 2023 ($0.78 Mil) to Jun. 2024 ($1.22 Mil) and increased from Jun. 2024 ($1.22 Mil) to Jun. 2025 ($3.18 Mil).

Imugene Other Current Payables Related Terms

Imugene Other Current Payables Historical Data

* Premium members only.

The historical data trend for Imugene's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imugene Other Current Payables Chart

Imugene Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.61 0.78 1.22 3.18

Imugene Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.22 0.00 3.18 0.00
IUGNF
30GF Score
Imugene Ltd IUGNF
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imugene Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Imugene (IUGNF) has a Other Current Payables of $0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Imugene and its competitors.
Is Imugene's Other Current Payables too high?
Imugene's current Other Current Payables is $0.00 Mil. Overall, Imugene has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Imugene's Other Current Payables compare to VRTX and REGN?
Imugene's Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Imugene and its competitors. Imugene's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imugene stock overvalued right now?
Imugene (IUGNF) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Imugene's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Imugene (IUGNF), the current Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imugene Business Description

Other Exchanges ILA:GermanyIMU:Australia
Address 4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Imugene Ltd is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumours. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.
30GF Score

Get the complete analysis for IUGNF

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price